Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

Enzon Pharmaceuticals Inc. (ENZN)

-NasdaqCM
1.09 Up 0.04(3.81%) Jul 11, 4:00PM EDT
Prev Close:1.05
Open:1.06
Bid:0.50 x 300
Ask:N/A
1y Target Est:14.00
Beta:1.28
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:1.06 - 1.10
52wk Range:0.78 - 2.09
Volume:160,960
Avg Vol (3m):553,027
Market Cap:48.06M
P/E (ttm):2.07
EPS (ttm):0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENZN

Comparison

Symbol% ChgMkt Cap
ENZNUp 3.81%48.06M
ISISUp 1.72%3.62B
NKTRUp 2.36%1.60B
PFEUp 0.23%191.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.39
Ex-Dividend Date:24-Dec-13

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enzon Pharmaceuticals, Inc. is engaged in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for Crohn’s disea... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback